SRX Global is trading at $1.10, up 5.77%, alongside strength in technology and AI-related shares.
- Renewed enthusiasm for AI followed Anthropic’s IPO filing; Reuters said the filing lifted risk appetite and supported technology stocks.
- SRX Global’s latest company announcement was October 26, reporting a new clinical-trial site for CERo’s Phase 1 trial.
- No October 27 company-specific catalyst appeared in company press-release listings; the October 26 announcement does not establish the reason for this session’s gain.